CARRENO, M. CARMEN;DOMINGUEZ, ENRIQUE;GARCIA-RUANO, JOSE L.;RUBIO, ALMUDE+, J. ORG. CHEM., 52,(1987) N 16, 3619-3625
作者:CARRENO, M. CARMEN、DOMINGUEZ, ENRIQUE、GARCIA-RUANO, JOSE L.、RUBIO, ALMUDE+
DOI:——
日期:——
PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS
申请人:Genentech, Inc.
公开号:US20220389020A1
公开(公告)日:2022-12-08
A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R
1
, R
2
and R
3
are defined herein, are useful as inhibitors of one or more Janus kinases. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient are disclosed.